s708A Notice & Appendix 3B
Released
Released
Announcement PDF
ASX Announcement
20 October 2014
_____________________________________________________________________________________
NOTICE UNDER SECTION 708A
COMPANY DETAILS
ABN: 62 147 346 334
PRINCIPAL AND
REGISTERED OFFICE
Potash West NL
Suite 3
23 Belgravia Street
Belmont WA 6104
POSTAL ADDRESS
PO Box 588
Belmont WA 6984
W www.potashwest.com.au
E info@potashwest.com.au
P +61 8 9479 5386
The Company has today issued 58,900,000 ordinary fully paid shares.
The ordinary fully paid shares are part of a class of securities quoted on the
Australian Securities Exchange Limited (ASX). The Company gives this notice
pursuant to Section 708A(5)(e) of the Corporations Act 2001.
The shares were issued without disclosure to private investors under Part 6D.2, in
reliance on Section 708A(5) of the Corporations Act 2001.
The Company, as at the date of this notice, has complied with:
a)
b)
the provisions of Chapter 2M of the Corporations Act 2001; and
Section 674 of the Corporations Act 2001.
There is no excluded information as at the date of this notice, for the purposes of
Sections 708A(7) and (8) of the Corporations Act 2001.
F +61 8 9475 0847
ASX CODE
PWN
OTC PINK
PWNNY
CORPORATE
INFORMATION
(20 October 2014)
196M Ordinary fully paid shares
36M Ordinary partly paid shares
5M Unlisted Options
8M Listed Options
BOARD OF DIRECTORS
Adrian Griffin
(Non-Executive Chairman)
Patrick McManus
(Managing Director)
George Sakalidis
(Non-Executive Director)
Gary Johnson
(Non-Executive Director)
For further information contact:
Potash West NL:
Patrick McManus
Managing Director
Tel: +61 (08) 9479 5386
info@potashwest.com.au
Web: www.potashwest.com.au
About Potash West
Potash West (ASX:PWN) is an exploration company focused on developing potassium-rich glauconite
deposits in West Australia’s Perth Basin. The Company aims to define a substantial resource base and
investigate how best to recover phosphate and potash from the mineral. The project is well situated in
relation to infrastructure, with close access to rail, power and gas. A successful commercial outcome
will allow the Company to become a major contributor to the fertilizer market at a time of heightened
demand. The Company has a major land holding over one of the world’s largest known glauconite
deposits, with exploration licenses and applications covering an area of more than 2,000km 2. Previous
exploration indicates glauconite sediments are widespread for more than 150km along strike and
30km in width.
Appendix 3B
New issue announcement
Rule 2.7, 3.10.3, 3.10.4, 3.10.5
Appendix 3B
New issue announcement,
application for quotation of additional securities
and agreement
Information or documents not available now must be given to ASX as soon as available. Information and
documents given to ASX become ASX’s property and may be made public.
Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13
Name of entity
Potash West NL
ABN
62 147 346 334
We (the entity) give ASX the following information.
Part 1 - All issues
You must complete the relevant sections (attach sheets if there is not enough space).
1
+Class of +securities issued or to
be issued
(i)
(ii)
(iii)
(iv)
Ordinary Fully Paid Shares
Ordinary Fully Paid Shares
Ordinary Fully Paid Shares
Ordinary Fully Paid Shares
2
Number of +securities issued or to
be issued (if known) or maximum
number which may be issued
(i)
(ii)
(iii)
(iv)
56,400,000
250,000
1,250,000
1,000,000
3
Principal terms of the +securities
(e.g. if options, exercise price and
expiry date; if partly paid
+securities, the amount outstanding
and due dates for payment; if
+convertible
securities,
the
conversion price and dates for
conversion)
(i)
(ii)
(iii)
(iv)
Ordinary Fully Paid Shares
Ordinary Fully Paid Shares
Ordinary Fully Paid Shares
Ordinary Fully Paid Shares
+ See chapter 19 for defined terms.
04/03/2013
Appendix 3B Page 1
Appendix 3B
New issue announcement
4
Do the +securities rank equally in
all respects from the +issue date
with an existing +class of quoted
+securities?
(i)
(ii)
(iii)
(iv)
Yes
Yes
Yes
Yes
(i)
(ii)
(iii)
(iv)
$0.05 per share
Deemed price of $0.05 per share
Deemed price of $0.035 per share
Deemed price of $0.05 per share
If the additional +securities do not
rank equally, please state:
the date from which they do
the extent to which they
participate for the next
dividend, (in the case of a trust,
distribution)
or
interest
payment
the extent to which they do not
rank equally, other than in
relation to the next dividend,
distribution or interest payment
5
Issue price or consideration
6
Purpose of the issue
(i)
(If issued as consideration for the (ii)
acquisition of assets, clearly
identify those assets)
(iii)
(iv)
6a
Is the entity an +eligible entity that
has obtained security holder
approval under rule 7.1A?
Placement announced 10 October 2014
In lieu of cash payments for investor
relations services
In lieu of cash payments for capital
raising services
In lieu of cash payments for tenement
data
Yes
If Yes, complete sections 6b – 6h
in relation to the +securities the
subject of this Appendix 3B, and
comply with section 6i
6b
The date the security holder
resolution under rule 7.1A was
passed
6c
Number of +securities issued
without security holder approval
under rule 7.1
25 November 2013
(i)
(ii)
(iii)
(iv)
16,400,000
250,000
1,250,000
1,000,000
+ See chapter 19 for defined terms.
Appendix 3B Page 2
04/03/2013
Appendix 3B
New issue announcement
6d
Number of +securities issued with
security holder approval under rule
7.1A
6e
Number of +securities issued with
security holder approval under rule
7.3, or another specific security
holder approval (specify date of
meeting)
6f
Number of +securities issued under
an exception in rule 7.2
Nil
6g
If +securities issued under rule
7.1A, was issue price at least 75%
of 15 day VWAP as calculated
under rule 7.1A.3? Include the
+issue date and both values.
Include the source of the VWAP
calculation.
N/A
6h
If +securities were issued under
rule
7.1A
for
non-cash
consideration, state date on which
valuation of consideration was
released
to
ASX
Market
Announcements
N/A
6i
Calculate the entity’s remaining
issue capacity under rule 7.1 and
rule 7.1A – complete Annexure 1
and release to ASX Market
Announcements
Refer Annexure 1
7
+Issue dates
20 October 2014
Nil
(i)
40,000,000 Ordinary Fully Paid
Shares
Note: The issue date may be prescribed by ASX
(refer to the definition of issue date in rule 19.12).
For example, the issue date for a pro rata
entitlement issue must comply with the applicable
timetable in Appendix 7A.
Cross reference: item 33 of Appendix 3B.
8
Number
all 196,314,005
Number and +class of
+securities
quoted on ASX
(including the +securities in section
2 if applicable)
+Class
Ordinary Fully Paid
Shares
35,960,024
Ordinary Partly Paid
Shares
(paid
to
$0.001,
unpaid
$0.049)
8,221,457
$0.300 listed options
expiring 15 March
2015
+ See chapter 19 for defined terms.
04/03/2013
Appendix 3B Page 1
Appendix 3B
New issue announcement
9
10
Number
all 1,250,000
+class
Number and
of
+securities not quoted on ASX
(including the +securities in section
2 if applicable)
Dividend policy (in the case of a
trust, distribution policy) on the
increased capital (interests)
+Class
$0.280 unlisted
options expiring 30
November 2014
1,000,000
$0.130 unlisted
options expiring 25
October 2015
1,350,000
$0.355 unlisted
options expiring 13
November 2015
100,000
$0.400 unlisted
options expiring 8
September 2016
100,000
$0.600 unlisted
options expiring 8
September 2016
500,000
$0.15 unlisted options
expiring 7 February
2017
N/A
Part 2 - Pro rata issue
11
Is
security
required?
holder
approval
12
Is the issue renounceable or nonrenounceable?
13
Ratio in which the +securities will
be offered
14
+Class
15
+Record
of +securities to which the
offer relates
date
to
determine
entitlements
+ See chapter 19 for defined terms.
Appendix 3B Page 4
04/03/2013
Appendix 3B
New issue announcement
16
Will holdings on different registers
(or subregisters) be aggregated for
calculating entitlements?
17
Policy for deciding entitlements in
relation to fractions
18
Names of countries in which the
entity has security holders who will
not be sent new offer documents
Note: Security holders must be told how their
entitlements are to be dealt with.
Cross reference: rule 7.7.
19
Closing date for receipt
acceptances or renunciations
of
20
Names of any underwriters
21
Amount of any underwriting fee or
commission
22
Names of any brokers to the issue
23
Fee or commission payable to the
broker to the issue
24
Amount of any handling fee
payable to brokers who lodge
acceptances or renunciations on
behalf of security holders
25
If the issue is contingent on security
holders’ approval, the date of the
meeting
26
Date entitlement and acceptance
form and offer documents will be
sent to persons entitled
27
If the entity has issued options, and
the terms entitle option holders to
participate on exercise, the date on
which notices will be sent to option
holders
28
Date rights trading will begin (if
applicable)
+ See chapter 19 for defined terms.
04/03/2013
Appendix 3B Page 1
Appendix 3B
New issue announcement
29
Date rights trading will end (if
applicable)
30
How do security holders sell their
entitlements in full through a
broker?
31
How do security holders sell part of
their entitlements through a broker
and accept for the balance?
32
How do security holders dispose of
their entitlements (except by sale
through a broker)?
33
+Issue date
Part 3 - Quotation of securities
You need only complete this section if you are applying for quotation of securities
34
Type of +securities
(tick one)
(a)
+Securities described in Part 1
(b)
All other +securities
Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee
incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities
Entities that have ticked box 34(a)
Additional securities forming a new class of securities
Tick to indicate you are providing the information or
documents
35
If the +securities are +equity securities, the names of the 20 largest holders of the
additional +securities, and the number and percentage of additional +securities held by
those holders
36
If the +securities are +equity securities, a distribution schedule of the additional
+securities setting out the number of holders in the categories
1 - 1,000
1,001 - 5,000
5,001 - 10,000
10,001 - 100,000
100,001 and over
+ See chapter 19 for defined terms.
Appendix 3B Page 6
04/03/2013
Appendix 3B
New issue announcement
A copy of any trust deed for the additional +securities
37
Entities that have ticked box 34(b)
38
Number of +securities for which
+quotation is sought
39
+Class
40
Do the +securities rank equally in all
respects from the +issue date with an
existing +class of quoted +securities?
of +securities for which
quotation is sought
If the additional +securities do not
rank equally, please state:
the date from which they do
the extent to which they
participate for the next dividend,
(in the case of a trust,
distribution) or interest payment
the extent to which they do not
rank equally, other than in
relation to the next dividend,
distribution or interest payment
41
Reason for request for quotation
now
Example: In the case of restricted securities, end of
restriction period
(if issued upon conversion of
another +security, clearly identify
that other +security)
Number
42
+Class
Number and +class of all +securities
quoted on ASX (including the
+securities in clause 38)
+ See chapter 19 for defined terms.
04/03/2013
Appendix 3B Page 1
Appendix 3B
New issue announcement
Quotation agreement
1
+Quotation of our additional +securities is in ASX’s absolute discretion.
ASX may
quote the +securities on any conditions it decides.
2
We warrant the following to ASX.
The issue of the +securities to be quoted complies with the law and is not for
an illegal purpose.
There is no reason why those +securities should not be granted +quotation.
An offer of the +securities for sale within 12 months after their issue will
not require disclosure under section 707(3) or section 1012C(6) of the
Corporations Act.
Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give
this warranty
Section 724 or section 1016E of the Corporations Act does not apply to any
applications received by us in relation to any +securities to be quoted and
that no-one has any right to return any +securities to be quoted under
sections 737, 738 or 1016F of the Corporations Act at the time that we
request that the +securities be quoted.
If we are a trust, we warrant that no person has the right to return the
+securities to be quoted under section 1019B of the Corporations Act at the
time that we request that the +securities be quoted.
3
We will indemnify ASX to the fullest extent permitted by law in respect of any
claim, action or expense arising from or connected with any breach of the warranties
in this agreement.
4
We give ASX the information and documents required by this form. If any
information or document is not available now, we will give it to ASX before
+quotation of the +securities begins. We acknowledge that ASX is relying on the
information and documents. We warrant that they are (will be) true and complete.
Sign here:
Date: 20 October 2014
Director
Print name:
Patrick McManus
== == == == ==
+ See chapter 19 for defined terms.
Appendix 3B Page 8
04/03/2013
Appendix 3B
New issue announcement
Appendix 3B – Annexure 1
Calculation of placement capacity under rule 7.1 and rule
7.1A for eligible entities
Introduced 01/08/12 Amended 04/03/13
Part 1
Rule 7.1 – Issues exceeding 15% of capital
Step 1: Calculate “A”, the base figure from which the placement capacity is
calculated
Insert number of fully paid +ordinary securities
on issue 12 months before the +issue date or
date of agreement to issue
92,021,064
Add the following:
•
Number of fully paid +ordinary securities
issued in that 12 month period under an
exception in rule 7.2
54,784,237
•
Number of fully paid +ordinary securities
issued in that 12 month period with
shareholder approval
66,107,857
•
Number of partly paid +ordinary securities
that became fully paid in that 12 month
period
460,871
Nil
Note:
• Include only ordinary securities here –
other classes of equity securities cannot be
added
• Include here (if applicable) the securities
the subject of the Appendix 3B to which this
form is annexed
• It may be useful to set out issues of
securities on different dates as separate line
items
Subtract the number of fully paid +ordinary
securities cancelled during that 12 month period
Nil
“A”
178,133,205
+ See chapter 19 for defined terms.
04/03/2013
Appendix 3B Page 9
Appendix 3B
New issue announcement
Step 2: Calculate 15% of “A”
“B”
0.15
[Note: this value cannot be changed]
Multiply “A” by 0.15
26,719,981
Step 3: Calculate “C”, the amount of placement capacity under rule 7.1 that has
already been used
Insert number of +equity securities issued or
agreed to be issued in that 12 month period not
counting those issued:
•
Under an exception in rule 7.2
•
Under rule 7.1A
•
With security holder approval under rule 7.1
or rule 7.4
18,900,000 fully paid ordinary shares (this
notice)
Note:
• This applies to equity securities, unless
specifically excluded – not just ordinary
securities
• Include here (if applicable) the securities
the subject of the Appendix 3B to which this
form is annexed
• It may be useful to set out issues of
securities on different dates as separate line
items
“C”
18,900,000
Step 4: Subtract “C” from [“A” x “B”] to calculate remaining placement
capacity under rule 7.1
“A” x 0.15
26,719,981
Note: number must be same as shown in Step 2
Subtract “C”
18,900,000
Note: number must be same as shown in Step 3
Total [“A” x 0.15] – “C”
7,819,981
[Note: this is the remaining placement capacity
under rule 7.1]
+ See chapter 19 for defined terms.
Appendix 3B Page 10
04/03/2013
Appendix 3B
New issue announcement
Part 2
Rule 7.1A – Additional placement capacity for eligible entities
Step 1: Calculate “A”, the base figure from which the placement capacity is
calculated
“A”
178,133,205
Note: number must be same as shown in Step 1
of Part 1
Step 2: Calculate 10% of “A”
“D”
0.10
Note: this value cannot be changed
Multiply “A” by 0.10
17,813,321
Step 3: Calculate “E”, the amount of placement capacity under rule 7.1A that
has already been used
Insert number of +equity securities issued or
agreed to be issued in that 12 month period
under rule 7.1A
Nil
Notes:
• This applies to equity securities – not just
ordinary securities
• Include here – if applicable – the securities
the subject of the Appendix 3B to which this
form is annexed
• Do not include equity securities issued
under rule 7.1 (they must be dealt with in
Part 1), or for which specific security holder
approval has been obtained
• It may be useful to set out issues of
securities on different dates as separate line
items
“E”
Nil
+ See chapter 19 for defined terms.
04/03/2013
Appendix 3B Page 11
Appendix 3B
New issue announcement
Step 4: Subtract “E” from [“A” x “D”] to calculate remaining placement
capacity under rule 7.1A
“A” x 0.10
17,813,321
Note: number must be same as shown in Step 2
Subtract “E”
Nil
Note: number must be same as shown in Step 3
Total [“A” x 0.10] – “E”
17,813,321
Note: this is the remaining placement capacity
under rule 7.1A
+ See chapter 19 for defined terms.
Appendix 3B Page 12
04/03/2013
Share your feedback
Discover